Antje Beling Selected Research

PR-957

1/2021	Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection.
1/2020	ONX 0914 Lacks Selectivity for the Cardiac Immunoproteasome in CoxsackievirusB3 Myocarditis of NMRI Mice and Promotes Virus-Mediated Tissue Damage.
1/2020	Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
1/2018	The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antje Beling Research Topics

Disease

12	Infections 01/2022 - 01/2018
11	Myocarditis (Carditis) 01/2021 - 01/2017
6	Inflammation (Inflammations) 01/2021 - 01/2018
2	Neoplasms (Cancer) 01/2020 - 01/2018
2	Cicatrix (Scar) 01/2020 - 11/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Heart Diseases (Heart Disease) 01/2018 - 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021
1	Moyamoya Disease (Moya-Moya Disease) 10/2021
1	Pancreatitis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2019
1	Cardiomyopathies (Cardiomyopathy) 11/2019
1	Sepsis (Septicemia) 01/2018

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2020 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2017
4	PR-957IBA 01/2021 - 01/2018
2	Cysteine (L-Cysteine)FDA Link 01/2022 - 01/2018
2	EnzymesIBA 11/2021 - 11/2019
2	UbiquitinsIBA 11/2021 - 10/2021
2	InterferonsIBA 11/2021 - 10/2021
2	ChemokinesIBA 01/2020 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2019
2	Immunoglobulin G (IgG)IBA 01/2020 - 11/2019
2	Peptides (Polypeptides)IBA 01/2020 - 01/2017
1	Alanine (L-Alanine)FDA Link 01/2022
1	UbiquitinIBA 11/2021
1	Blocking AntibodiesIBA 01/2021
1	CD55 Antigens (Decay Accelerating Factor)IBA 01/2021
1	PolyubiquitinIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Troponin IIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Viral RNAIBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Tramadol (K315)FDA LinkGeneric 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Virus ReceptorsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	adenovirus receptorIBA 11/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2018

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2019
1	Analgesia 01/2021